Hemostemix Inc. (CVE:HEM – Get Free Report) shares passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$0.10 and traded as low as C$0.09. Hemostemix shares last traded at C$0.10, with a volume of 368,500 shares traded.
Hemostemix Stock Down 5.0%
The company has a debt-to-equity ratio of -55.07, a quick ratio of 0.48 and a current ratio of 0.04. The stock has a 50 day moving average price of C$0.10 and a 200 day moving average price of C$0.11. The company has a market cap of C$17.20 million, a P/E ratio of -3.52 and a beta of 0.85.
About Hemostemix
Hemostemix Inc, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia.
Further Reading
- Five stocks we like better than Hemostemix
- Profitably Trade Stocks at 52-Week Highs
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- Investing In Automotive Stocks
- The Best Local Butchers for Thanksgiving [2025 Survey]
- Best Stocks Under $10.00
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Receive News & Ratings for Hemostemix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemostemix and related companies with MarketBeat.com's FREE daily email newsletter.
